Italia markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
3,7000+0,2300 (+6,63%)
Alla chiusura: 04:00PM EDT
4,0000 +0,30 (+8,11%)
Dopo ore: 07:49PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente3,4700
Aperto3,4800
Denaro3,6700 x 200
Domanda3,7600 x 200
Min-Max giorno3,4800 - 3,7500
Intervallo di 52 settimane1,5600 - 4,4900
Volume73.568
Media Volume1.451.692
Capitalizzazione53,676M
Beta (mensile su 5 anni)0,88
Rapporto PE (ttm)N/D
EPS (ttm)-0,4200
Prossima data utili19 lug 2024 - 23 lug 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    ARCA biopharma Announces Second Quarter 2023 Financial Results

    Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Di